vs
亚什兰（ASH）与KRONOS WORLDWIDE INC（KRO）财务数据对比。点击上方公司名可切换其他公司
KRONOS WORLDWIDE INC的季度营收约是亚什兰的1.1倍（$418.3M vs $386.0M），亚什兰净利率更高（-3.1% vs -19.8%，领先16.7%），KRONOS WORLDWIDE INC同比增速更快（-1.1% vs -4.7%），亚什兰自由现金流更多（$111.0M vs $81.9M），过去两年KRONOS WORLDWIDE INC的营收复合增速更高（-6.5% vs -18.1%）
亚什兰是一家总部位于美国特拉华州威尔明顿的化工企业，1924年始创于肯塔基州亚什兰市，最初以炼油业务起家，1994年迁至现总部。公司拥有多个业务板块，覆盖化工中间体与溶剂、复合材料、工业特种化学品、个人及家居护理、制药、食品饮料以及农业相关领域，2017年之前曾是胜牌润滑油的主要生产商。
克罗诺斯全球（原克罗诺斯公司）是一家美国跨国企业，总部位于美国马萨诸塞州洛厄尔，专注于提供劳动力管理与人力资本管理云服务，在全球拥有超过6000名员工，是该领域知名的服务提供商。
ASH vs KRO — 直观对比
营收规模更大
KRO
是对方的1.1倍
$386.0M
营收增速更快
KRO
高出3.6%
-4.7%
净利率更高
ASH
高出16.7%
-19.8%
自由现金流更多
ASH
多$29.1M
$81.9M
两年增速更快
KRO
近两年复合增速
-18.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $386.0M | $418.3M |
| 净利润 | $-12.0M | $-82.8M |
| 毛利率 | 27.2% | -0.9% |
| 营业利润率 | -1.6% | -15.1% |
| 净利率 | -3.1% | -19.8% |
| 营收同比 | -4.7% | -1.1% |
| 净利润同比 | 92.7% | -527.3% |
| 每股收益（稀释后） | $-0.26 | $-0.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASHKRO
| Q4 25 | $386.0M | $418.3M | ||
| Q3 25 | $477.0M | $456.9M | ||
| Q2 25 | $463.0M | $494.4M | ||
| Q1 25 | $479.0M | $489.8M | ||
| Q4 24 | $405.0M | $423.1M | ||
| Q3 24 | $521.0M | $484.7M | ||
| Q2 24 | $544.0M | $500.5M | ||
| Q1 24 | $575.0M | $478.8M |
净利润ASHKRO
| Q4 25 | $-12.0M | $-82.8M | ||
| Q3 25 | $31.0M | $-37.0M | ||
| Q2 25 | $-742.0M | $-9.2M | ||
| Q1 25 | $31.0M | $18.1M | ||
| Q4 24 | $-165.0M | $-13.2M | ||
| Q3 24 | $17.0M | $71.8M | ||
| Q2 24 | $6.0M | $19.5M | ||
| Q1 24 | $120.0M | $8.1M |
毛利率ASHKRO
| Q4 25 | 27.2% | -0.9% | ||
| Q3 25 | 33.3% | 10.3% | ||
| Q2 25 | 28.5% | 12.7% | ||
| Q1 25 | 30.7% | 21.8% | ||
| Q4 24 | 27.4% | 20.4% | ||
| Q3 24 | 33.2% | 20.9% | ||
| Q2 24 | 34.2% | 20.0% | ||
| Q1 24 | 28.0% | 14.9% |
营业利润率ASHKRO
| Q4 25 | -1.6% | -15.1% | ||
| Q3 25 | 12.8% | -4.2% | ||
| Q2 25 | -152.9% | 1.5% | ||
| Q1 25 | 10.6% | 7.8% | ||
| Q4 24 | -44.2% | 6.8% | ||
| Q3 24 | 6.1% | 8.0% | ||
| Q2 24 | -11.2% | 7.2% | ||
| Q1 24 | 3.7% | 4.1% |
净利率ASHKRO
| Q4 25 | -3.1% | -19.8% | ||
| Q3 25 | 6.5% | -8.1% | ||
| Q2 25 | -160.3% | -1.9% | ||
| Q1 25 | 6.5% | 3.7% | ||
| Q4 24 | -40.7% | -3.1% | ||
| Q3 24 | 3.3% | 14.8% | ||
| Q2 24 | 1.1% | 3.9% | ||
| Q1 24 | 20.9% | 1.7% |
每股收益（稀释后）ASHKRO
| Q4 25 | $-0.26 | $-0.72 | ||
| Q3 25 | $0.83 | $-0.32 | ||
| Q2 25 | $-16.21 | $-0.08 | ||
| Q1 25 | $0.65 | $0.16 | ||
| Q4 24 | $-3.50 | $-0.11 | ||
| Q3 24 | $0.34 | $0.62 | ||
| Q2 24 | $0.12 | $0.17 | ||
| Q1 24 | $2.39 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $304.0M | $33.2M |
| 总债务越低越好 | $1.4B | $557.4M |
| 股东权益账面价值 | $1.9B | $751.1M |
| 总资产 | $4.5B | $1.8B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.74× |
8季度趋势，按日历期对齐
现金及短期投资ASHKRO
| Q4 25 | $304.0M | $33.2M | ||
| Q3 25 | $215.0M | $27.7M | ||
| Q2 25 | $207.0M | $18.9M | ||
| Q1 25 | $168.0M | $20.5M | ||
| Q4 24 | $219.0M | $106.7M | ||
| Q3 24 | $300.0M | $94.8M | ||
| Q2 24 | $399.0M | $133.8M | ||
| Q1 24 | $439.0M | $120.7M |
总债务ASHKRO
| Q4 25 | $1.4B | $557.4M | ||
| Q3 25 | $1.4B | $626.2M | ||
| Q2 25 | $1.4B | $589.3M | ||
| Q1 25 | $1.3B | $557.2M | ||
| Q4 24 | $1.3B | $507.4M | ||
| Q3 24 | $1.3B | $554.3M | ||
| Q2 24 | $1.3B | $423.7M | ||
| Q1 24 | $1.3B | $426.9M |
股东权益ASHKRO
| Q4 25 | $1.9B | $751.1M | ||
| Q3 25 | $1.9B | $804.7M | ||
| Q2 25 | $1.9B | $846.8M | ||
| Q1 25 | $2.6B | $847.0M | ||
| Q4 24 | $2.6B | $817.0M | ||
| Q3 24 | $2.9B | $847.4M | ||
| Q2 24 | $3.0B | $774.6M | ||
| Q1 24 | $3.1B | $774.4M |
总资产ASHKRO
| Q4 25 | $4.5B | $1.8B | ||
| Q3 25 | $4.6B | $1.9B | ||
| Q2 25 | $4.6B | $1.9B | ||
| Q1 25 | $5.2B | $1.9B | ||
| Q4 24 | $5.2B | $1.9B | ||
| Q3 24 | $5.6B | $1.9B | ||
| Q2 24 | $5.7B | $1.7B | ||
| Q1 24 | $5.9B | $1.7B |
负债/权益比ASHKRO
| Q4 25 | 0.74× | 0.74× | ||
| Q3 25 | 0.73× | 0.78× | ||
| Q2 25 | 0.73× | 0.70× | ||
| Q1 25 | 0.52× | 0.66× | ||
| Q4 24 | 0.51× | 0.62× | ||
| Q3 24 | 0.47× | 0.65× | ||
| Q2 24 | 0.45× | 0.55× | ||
| Q1 24 | 0.42× | 0.55× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $125.0M | $92.1M |
| 自由现金流经营现金流 - 资本支出 | $111.0M | $81.9M |
| 自由现金流率自由现金流/营收 | 28.8% | 19.6% |
| 资本支出强度资本支出/营收 | 3.6% | 2.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $200.0M | $-40.4M |
8季度趋势，按日历期对齐
经营现金流ASHKRO
| Q4 25 | $125.0M | $92.1M | ||
| Q3 25 | $40.0M | $-7.9M | ||
| Q2 25 | $115.0M | $20.7M | ||
| Q1 25 | $9.0M | $-102.4M | ||
| Q4 24 | $-30.0M | $49.3M | ||
| Q3 24 | $80.0M | $28.3M | ||
| Q2 24 | $127.0M | $38.2M | ||
| Q1 24 | $54.0M | $-43.3M |
自由现金流ASHKRO
| Q4 25 | $111.0M | $81.9M | ||
| Q3 25 | $6.0M | $-17.4M | ||
| Q2 25 | $95.0M | $9.5M | ||
| Q1 25 | $-12.0M | $-114.4M | ||
| Q4 24 | $-53.0M | $37.0M | ||
| Q3 24 | $42.0M | $19.2M | ||
| Q2 24 | $98.0M | $34.8M | ||
| Q1 24 | $20.0M | $-48.0M |
自由现金流率ASHKRO
| Q4 25 | 28.8% | 19.6% | ||
| Q3 25 | 1.3% | -3.8% | ||
| Q2 25 | 20.5% | 1.9% | ||
| Q1 25 | -2.5% | -23.4% | ||
| Q4 24 | -13.1% | 8.7% | ||
| Q3 24 | 8.1% | 4.0% | ||
| Q2 24 | 18.0% | 7.0% | ||
| Q1 24 | 3.5% | -10.0% |
资本支出强度ASHKRO
| Q4 25 | 3.6% | 2.4% | ||
| Q3 25 | 7.1% | 2.1% | ||
| Q2 25 | 4.3% | 2.3% | ||
| Q1 25 | 4.4% | 2.4% | ||
| Q4 24 | 5.7% | 2.9% | ||
| Q3 24 | 7.3% | 1.9% | ||
| Q2 24 | 5.3% | 0.7% | ||
| Q1 24 | 5.9% | 1.0% |
现金转化率ASHKRO
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.29× | -5.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | 4.71× | 0.39× | ||
| Q2 24 | 21.17× | 1.96× | ||
| Q1 24 | 0.45× | -5.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASH
| Personal Care And Household | $123.0M | 32% |
| Other | $120.0M | 31% |
| Specialty Additives | $36.0M | 9% |
| Intermediates And Solvents | $31.0M | 8% |
| Personal Care | $30.0M | 8% |
| Life Sciences | $27.0M | 7% |
| Intermediates | $19.0M | 5% |
KRO
暂无分部数据
